Perfluorochemical-Based Oxygen Therapeutics, Contrast Agents, and Beyond

Fluorine and Health

Volumn , Issue , 2008, Pages 447-486

  Krafft, Marie Pierre ^a   Riess, Jean G ^b  

^a INSTITUT CHARLES SADRON   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882911336     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-444-53086-8.00011-4     Document Type: Chapter

References (107)

1. Müller K. ChemBioChem (Special Issue on Fluorine in the Life Science) 2004, 5:559-722.
2. Bégué J.P., Bonnet-Delpon D. Chimie Bioorganique et Médicinale du Fluor, EDP Sciences 2005, CNRS Editions, Paris.
3. Riess J.G. Fluorine at the Millennium 2000, 385-431. Elsevier, Amsterdam. R.E. Banks (Ed.).
4. Riess J.G. Fluorous micro- and nanophases with a biomedical perspective. Tetrahedron 2002, 58:4113-4131.
5. Riess J.G. Handbook of Fluorous Chemistry 2004, 521-573. Wiley-VCH, Weinheim. J.A. Gladysz, D.P. Curran, I. Horváth (Eds.).
6. Krafft M.P. Handbook of Fluorous Chemistry 2004, 478-490. Wiley-VCH, Weinheim. J.A. Gladysz, D.P. Curran, I.T. Horvath (Eds.).
7. Riess J.G. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif. Cells Blood Substit. Immob. Biotech. 2005, 33:47-63.
8. Riess J.G., Krafft M.P. Blood Substitutes 2006, 259-275. Elsevier, Amsterdam. R.M. Winslow (Ed.).
9. Krafft M.P., Riess J.G. Perfluorocarbons, life sciences and biomedical uses. J. Polym. Sci. Part A: Polym. Chem. 2007, 45:1185-1198.
10. Krafft M.P. Curr. Opin. Colloid Interf. Sci. (Special issue on Fluorinated Colloids and Interfaces) 2003, 8:213-314.
11. Lehn J.M. Towards self-organization and complex matter. Science 2002, 295:2400-2403.
12. Metrangolo P., Neukirch H., Pilati T., Resnati G. Halogen bonding based recognition processes: A world parallel to hydrogen bonding. Acc. Chem. Res. 2005, 38:386-395.
13. Gladysz J.A., Curran D.P. Fluorous Chemistry (A Special Issue of Tetrahedron) 2002, 58:3823-4131.
14. Gladysz J.A., Curran D.P., Horváth I. Handbook of Fluorous Chemistry 2004, Wiley-VCH, Weinheim.
15. Riess J.G., Krafft M.P. Fluorinated materials for in vivo oxygen transport (blood substitutes), diagnosis and drug delivery. Biomaterials 1998, 19:1529-1539.
16. Mattrey R.F., Trambert M.A., Brown J.J., Young S.W., Bruneton J.N., Wesbey G.E., Balsara Z.N. Perflubron as an oral contrast agent for MR imaging: Results of a phase III clinical trial. Radiology 1994, 191:841-848.
17. Leach C.L., Greenspan J.S., Rubenstein D., Shaffer T.H., Wolfson M.R., Jackson J.C., DeLemos R., Fuhrman B.P. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. New Engl. J. Med. 1996, 335:761-766.
18. Lau C., Butenhoff J.L., Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 2004, 198:231-241.
19. Krafft M.P., Riess J.G. Highly fluorinated amphiphiles and colloidal systems, and their applications in the biomedical field-A contribution. Biochimie 1998, 80:489-514.
20. Riess J.G. Injectable oxygen carriers (blood substitutes)-Raison d'être, chemistry and some physiology. Chem. Rev. 2001, 101:2797-2920.
21. Krafft M.P., Chittofrati A., Riess J.G. Emulsions and microemulsions with a fluorocarbon phase. Curr. Opin. Colloid Interface Sci. 2003, 8:251-258.
22. Riess J.G. Perfluorocarbon-based oxygen delivery. Artif. Cells Blood Substit. Immobil. Biotech. 2006, 34:567-580.
23. Krafft M.P., Riess J.G., Weers J.G. Submicronic Emulsions in Drug Targeting and Delivery 1998, 235-333. Harwood Academic Publication, Amsterdam. S. Benita (Ed.).
24. Ivanitsky G.R. Biophysics at the turn of the millennium: Perfluorocarbon media and gas-transporting blood substitutes. Biophysics 2001, 46:1-31.
25. Eckman D.M., Lomivorotov V.N. Microvascular gas embolization clearance following perfluorocarbon administration. J. Appl. Physiol. 2003, 94:860-868.
26. Keipert P.E. Blood Substitutes 2006, 312-323. Elsevier, Amsterdam. R.M. Winslow (Ed.).
27. Spahn D.R., Waschke K.F., Standl T., Motsch J., Van Huynegem L., Welte M., Gombotz H., Coriat P., Verkh L., Faithfull S., Keipert P. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: Results of a European Phase 3 study. Anesthesiology 2002, 97:1338-1349.
28. Faithfull N.S. The concept of hemoglobin equivalency of perfluorochemical emulsions. Adv. Exp. Med. Biol. 2003, 530:271-285.
29. Frumento R.J., Mongero L., Naka Y., Bennett-Guerrero E. Preserved gastric tonometric variables in cardiac surgical patients administered intravenous perflubron emulsion. Anesth. Analg. 2002, 94:809-814.
30. Yoshitani K., De Lange F., Ma Q., Grocott H.P., Mackensen G.B. Reduction in air bubble size using perfluorocarbons during cardiopulmonary bypass in the rat. Anesth. Analg. 2006, 103:1089-1093.
31. Marie Bertilla S., Thomas J.L., Marie P., Krafft M.P. Co-surfactant effect of a semifluorinated alkane at a fluorocarbon/water interface. Impact on the stabilization of fluorocarbon-in-water emulsions. Langmuir 2004, 20:3920-3924.
32. Audonnet-Blaise S., Krafft M.P., Smani Y., Mertes P.M., Marie P.Y., Labrude P., Longrois D., Menu P. Resuscitation of severe but brief haemorrhagic shock with PFC in rabbits restores skeletal muscle oxygen delivery and does not alter skeletal muscle metabolism. Resuscitation 2006, 70:124-132.
33. Lundgren C.E., Bergoe G.W., Tyssebotn I. The theory and application of intravascular microbubbles as an ultra-effective means of transporting oxygen and other gases. Undersea Hyperb. Med. 2004, 31:105-106.
34. Mulvagh S.L., DeMaria A.N., Feinstein S.B., Burns P.N., Kaul S., Miller J.G., Monaghan M., Porter T.R., Shaw L.J., Villanueva F.S. Contrast echography: Current and future applications. J. Am. Soc. Echocardiogr. 2000, 13:331-342.
35. Becher H., Burns P.N. Handbook of Contrast Echocardiography-Left Ventricular Function and Myocardial Perfusion 2000, Springer Verlag, Berlin.
36. Goldberg B.B., Raichlen J.S., Forsberg F. Ultrasound Contrast Agents-Basic Principles and Clinical Applications 2001, Martin Dunitz, London. 2nd edition.
37. Schutt E.S., Klein D.H., Mattrey R.M., Riess J.G. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: The key role of perfluorochemicals. Angew. Chem. Int. Ed. 2003, 42:3218-3235.
38. Cosgrove D. Ultrasound contrast agents: An overview. Eur. J. Radiol. 2006, 60:324-330.
39. Burns P.N., Wilson S.R. Microbubble contrast for radiological imaging: 1. Principles. Ultrasound Q. 2006, 22:5-13.
40. Kabalnov A., Klein D., Pelura T., Schutt E., Weers J. Dissolution of multicomponent microbubbles in the blood stream: 1. Theory. Ultrasound Med. Biol. 1998, 24:739-749.
41. Kabalnov A., Bradley J., Flaim S., Klein D., Pelura T., Peters B., Otto S., Reynolds J., Schutt E., Weers J. Dissolution of multicomponent microbubbles in the blood stream: 2. Experiment. Ultrasound Med. Biol. 1998, 24:751-760.
42. de Jong N., Bouakaz A., Ten Cate F.J. Contrast harmonic imaging. Ultrasonics 2002, 40:567-573.
43. Klibanov A.L., Rasche P.T., Hughes M.S., Wojdyla J.K., Galen K.P., Wible J.H., Brandenburger G.H. Detection of individual microbubbles of an ultrasound contrast agent: Fundamental and pulse inversion imaging. Acad. Radiol. 2002, 9(Suppl. 2):S279-S281.
44. Gerber F., Krafft M.P., Waton G., Vandamme T.F. Microbubbles with exceptionally long life-Synergy between shell and internal phase components. New J. Chem. 2006, 30:524-527.
45. Klibanov A.L. Microbubble contrast agents: Targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest. Radiol. 2005, 41:354-362.
46. Behm C.Z., Lindner J.R. Cellular and molecular imaging with targeted contrast ultrasound. Ultrasound Q. 2006, 22:67-72.
47. Weller G.E.R., Villanueva F.S., Tom E.M., Wagner W.R. Targeted ultrasound contrast agents: In vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. Biotechnol. Bioeng. 2005, 92:780-788.
48. Morawski A.M., Lanza G.A., Wickline S.A. Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr. Opin. Biotechnol. 2005, 16:89-92.
49. Caruthers S.D., Winter P.M., Wickline S.A., Lanza G.M. Targeted magnetic resonance imaging contrast agents. Methods Mol. Med. 2006, 124:387-400.
50. Hirschl R.B., Croce M., Gore D., Wiedemann H., Davis K., Bartlett R.H. Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2002, 165:781-787.
51. Meinhardt J.P., Friess U., Bender H.J., Hirschl R.B., Quintel M. Relationship among cardiac index, inspiration/expiration ratio, and perfluorocarbon dose during partial liquid ventilation in an oleic acid model of acute lung injury in sheep. J. Pediatr. Surg. 2005, 40:1395-1403.
52. Rotta A.T., Gunnarsson B., Hernan L.J., Fuhrman B.P., Steinhorn D.M. Partial liquid ventilation with perflubron attenuates in vivo oxidative damage to proteins and lipids. Crit. Care Med. 2000, 28:202-208.
53. 4 and interleukin-6 in bronchoalveolar lavage in surfactant-depleted newborn pigs. Pediatr. Res. 2002, 51:183-189.
54. Haeberle H.A., Nesti F., Dieterich H.J., Gatalica Z., Garofalo R.P. Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappaB activation. Am. J. Respir. Crit. Care Med. 2002, 165:1433-1438.
55. Kandler M.A., von der Hardt K., Schoof E., Dotsch J., Rascher W. Persistent improvement of gas exchange and lung mechanics by aerosolized perfluorocarbon. Am. J. Resp. Crit. Care Med. 2001, 164:31-35.
56. Bleyl J.U., Ragaller M., Tschöh U., Regner M., Hübler M., Kanzow M., Vincent O., Albrecht M. Changes in pulmonary function and oxygenation during application of perfluorocarbon vapor in healthy and oleic acid-injured animals. Crit. Care Med. 2002, 30:1340-1347.
57. von der Hardt K., Schoof E., Kandler M.A., Dötsch J., Rascher W. Aerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model. Pediatr. Res. 2002, 51:177-182.
58. Gama de Abreu M., Quelhas A.D., Spieth P., Bräuer G., Knels L., Kasper M., Pino A.V., Bleyl J.U., Hübler M., Bozza F., Salluh J., Kuhlisch E., Giannella-Neto A., Koch T. Comparative effects of vaporized perfluorohexane and partial liquid ventilation in oleic acid-induced lung injury. Anesthesiology 2006, 104:278-289.
59. Gerber F., Krafft M.P., Vandamme T.F., Goldmann M., Fontaine P. Preventing crystallization of phospholipids in monolayers: A new approach to lung surfactant therapy. Angew. Chem. Int. Ed. 2005, 44:2749-2752.
60. Unger E.C., Porter T., Culp W., Labell R., Matsunaga T., Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv. Drug Deliv. Rev. 2004, 56:1291-1314.
61. McDannold N.J., Vykhodtseva N.I., Hynynen K. Microbubble contrast agent with focused ultrasound to create brain lesion at low power levels: MR imaging and histologic study in rabbits. Radiology 2006, 241:95-106.
62. Meairs S., Alonso A. Ultrasound, microbubbles and the blood-brain barrier. Prog. Biophys. Mol. Biol. 2006, 93:354-362.
63. Lowe K.C. Perfluorochemical respiratory gas carriers: Benefits to cell culture systems. J. Fluorine Chem. 2002, 118:19-26.
64. Sanchez Dominguez M., Krafft M.P., Maillard E., Siegrist S., Belcourt A. Prevention of adhesion and promotion of pseudoislets formation from a b-cell line by fluorocarbon emulsions. ChemBioChem 2006, 7:1160-1163.
65. Butz N., Porté C., Courrier H., Krafft M.P., Vandamme T.F. Reverse water-in-fluorocarbon emulsions for use in pressurized metered-dose inhalers containing hydrofluoroalkane propellants. Int. J. Pharm. 2002, 238:257-269.
66. Novel Cosmetic Delivery Systems 1998, 195-219. Dekker, New York. M.P. Krafft, S. Magdassi, E. Touitou (Eds.).
67. Babak V.G., Stébé M.J. A review on highly concentrated emulsions: Physicochemical principles of formulation. J. Disp. Sci. Technol. 2002, 23:1-15.
68. Ha C.S., Gardella J.A. Surface chemistry of biodegradable polymers for drug delivery systems. Chem. Rev. 2005, 105:4205-4232.
69. Tanaka K., Kogoma M., Ogawa Y. Fluorinated polymer coatings on PLGA microcapsules for drug delivery system using atmospheric pressure glow plasma. Thin Solid Films 2006, 506-507:159-162.
70. Howard C.M., Forsberg F., Minimo C., Liu J.B., Merton D.A., Claudio P.P. Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents. J. Cell. Physiol. 2006, 209:413-421.
71. Ferrara K., Pollard R., Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Ann. Rev. Biomed. Engineer. 2007, 9:415-447.
72. Nicolson P.C., Vogt J. Soft contact lens polymers: An evolution. Biomaterials 2001, 22:3273-3283.
73. Kannan R.Y., Salacinski H.J., Butler P.E., Hamilton G., Seifalian A.M. Current status of prosthetic bypass grafts: A review. J. Biomed. Mater. Res. B: Appl. Biomater. 2005, 74B:570-581.
74. Larsen C.C., Kligman F., Kottke-Marchant K., Marchant R.E. The effect of RGD fluorosurfactant polymer modification of ePTFE on endothelial cell adhesion, growth, and function. Biomaterials 2006, 27:4846-4855.
75. Ernsting M.J., Bonin G.C., Yang M., Labow R.S., Santerre J.P. Generation of cell adhesive substitutes using peptide fluoroalkyl surface modifiers. Biomaterials 2005, 26:6536-6546.
76. Dong C., Huang F.L., Deng H., Schaffrath C., Spencer J.B., O'Hagan D., Naismith J.H. Crystal structure and mechanism of a bacterial fluorinating enzyme. Nature 2004, 427:561-565.
77. Lee H.Y., Lee K.H., Al-Hashimi H.M., Marsh E.N.G. Modulating protein structure with fluorous amino acids: Increased stability and native-like structure conferred on a 4-helix bundle protein by hexafluoroleucine. J. Am. Chem. Soc. 2006, 128:337-343.
78. Tang Y., Ghirlanda G., Vaidehi N., Kua J., Mainz D.T., Goddard W.A., DeGrado W.F., Tirrell D.A. Stabilization of coiled-coil peptide domains by introduction of trifluoroleucine. Biochemistry 2001, 40:2790-2796.
79. Panza J.L., Russell A.J., Beckman E.J. Synthesis of fluorinated NAD as a soluble coenzyme for enzymatic chemistry in fluorous solvents and carbon dioxide. Tetrahedron 2002, 58:4091-4104.
80. Bilgiçer B., Xing X., Kumar K. Programmed self-sorting of coiled coils with leucine and hexafluoroleucine cores. J. Am. Chem. Soc. 2001, 123:11815-11816.
81. Bilgiçer B., Kumar K. De novo design of defined helical bundles in membrane environments. Proc. Natl. Acad. Sci. USA 2004, 101:15324-15329.
82. Naarmann N., Bilgiçer B., Meng H., Kumar K., Steinem C. Fluorinated interfaces drive self-association of transmembrane a helices in lipid bilayers. Angew. Chem. Int. Ed. 2006, 45:2588-2591.
83. Jäckel C., Salwiczek M., Koksch B. Fluorine in a native protein environment-How the spatial demand and polarity of fluoroalkyl groups affect protein folding. Angew. Chem. Int. Ed. 2006, 45:4198-4203.
84. Wang P., Tang Y., Tirrell D.A. Incorporation of trifluoroisoleucine into proteins in vivo. J. Am. Chem. Soc. 2003, 125:6900-6906.
85. Lai J.S., Kool E.T. Selective pairing of polyfluorinated DNA bases. J. Am. Chem. Soc. 2004, 126:3040-3041.
86. Lai J.S., Kool E.T. Fluorous base-pairing effects in a DNA polymerase active site. Chem. Europ. J. 2005, 11:2966-2971.
87. Ringsdorf H., Lehmann P., Weberskirch R. Multicompartmentation-a concept for the molecular architecture of life 1999.
88. Stähler K., Selb J., Candau F. Multicompartment polymeric micelles based on hydrocarbon and fluorocarbon polymerizable surfactants. Langmuir 1999, 15:7565-7576.
89. Kubowicz S., Baussard J.F., Lutz J.F., Thünemann A.F., von Berlepsch H., Laschewsky A. Multicompartment micelles formed by self-assembly of linear ABC triblock copolymers in aqueous medium. Angew. Chem. Int. Ed. 2005, 44:5262-5265.
90. Li Z., Kesselman E., Talmon Y., Hillmeyer M.A., Lodge T.P. Multicompartment micelles from ABC miktoarm stars in water. Science 2004, 306:98-101.
91. Sato S., Iida J., Suzuki K., Kawano M., Ozeki T., Fujita M. Fluorous nanodroplets structurally confined in an organopalladium sphere. Science 2006, 313:1273-1276.
92. Garcia-Bernabé A., Krämer M., Olàh B., Haag R. Syntheses and phase-transfer properties of dendritic nanocarriers that contain perfluorinated shell structures. Chem. Eur. J. 2004, 10:2822-2830.
93. Caminade A.M., Turrin C.O., Sutra P., Majoral J.P. Fluorinated dendrimers. Curr. Opin. Colloid Interf. Sci. 2003, 8:282-295.
94. Percec V., Glodde M., Peterca M., Rapp A., Schnell I., Spiess H.W., Bera T.K., Miura Y., Balagurusamy V.S.K., Aqad E., Heiney P.A. Self-assembly of semifluorinated dendrons attached to electron-donor groups mediates their p-stacking via a helical pyramidal column. Chem. Eur. J. 2006, 12:6298-6314.
95. Krafft M.P., Schieldknecht L., Marie P., Giulieri F., Schmutz M., Poulain N., Nakkache E. Fluorinated vesicles allow intrabilayer polymerization of a hydrophobic monomer, yielding polymerized microcapsules. Langmuir 2001, 17:2872-2877.
96. Brubach J.B., Mermet A., Filabozzi A., Gerschel A., Lairez D., Krafft M.P., Roy P. Dependence of water dynamics upon confinement size. J. Phys. Chem. B 2001, 105:430-435.
97. Maruyama T., Kotani T., Yamamura H., Kamiya N., Goto M. Poly(ethylene glycol)-lipase complexes catalytically active in fluorous solvents. Org. Biomol. Chem. 2004, 2:524-527.
98. Fontaine P., Goldmann M., Muller P., Faure M.C., Konovalov O., Krafft M.P. Direct evidence for highly organized networks of circular surface micelles of surfactant at the air/water interface. J. Am. Chem. Soc. 2005, 127:512-513.
99. Maaloum M., Muller P., Krafft M.P. Lateral and vertical nanophase separation in Langmuir-Blodgett films of phospholipids and semifluorinated alkanes. Langmuir 2004, 20:2261-2264.
100. Lebeau L., Lach F., Vénien-Bryan C., Renault A., Dietrich J., Jahn T., Palmgren M.G., Kühlbrandt W., Mioskowski C. Two-dimensional crystallization of a membrane protein on a detergent-resistant lipid monolayer. J. Mol. Biol. 2001, 308:639-647.
101. Whitesides G.M. The origins and the future of microfluidics. Nature 2006, 442:368-373.
102. Chen D.L., Ismagilov R.F. Microfluidic cartridges preloaded with nanoliter plugs of reagents: An alternative to 96-well plates for screening. Curr. Opin. Chem. Biol. 2006, 10:226-231.
103. Linder V., Sia S.K., Whitesides G.M. Reagent-loaded cartridges for valveless and automated fluid delivery in microfluidic devices. Anal. Chem. 2005, 77:64-71.
104. Zheng B., Gerdts C.J., Ismagilov R.F. Using nanoliter plugs in microfluidics to facilitate and understand protein crystallization. Curr. Opin. Struct. Biol. 2005, 15:548-555.
105. Advances in Blood Substitutes 1997, 91-132. Birkhäuser, Boston. S.F. Flaim, R.M. Winslow, K.D. Vandegriff, M. Intaglietta (Eds.).
106. Nanda N.C., Kitzman D.W., Crouse L.J., Dittrich H.C. Imagent improves endocardial border delineation, inter-reader agreement, and the accuracy of segmental wall motion assessment. Echocardiography 2003, 20:151-161.
107. Gerber F., Krafft M.P., Vandamme T.F., Goldman M., Fontaine P. Fluidization of a dipalmitoyl phosphatidylcholine monolayer by fluorocarbon gases: Potential use in lung surfactant therapy. Biophys. J. 2006, 90:3184-3192.